Lenmeldy, a lifesaving gene therapy, is the world’s most expensive drug
Lenmeldy, a new gene therapy for the rare and fatal childhood disease metachromatic leukodystrophy (MLD), has become the world’s most expensive drug, at a whopping $4.25 million (£3.350 million). MLD is a brutal illness that strikes toddlers and affects …